How can medical technology startups successfully navigate strict regulatory pathways without slowing down their path to market?
In this interview from the Med-Tech Expo 2026 show floor, Laurie Rowe, Founder of Red MedTech breaks down why traditional “late-stage” compliance planning is a major commercial risk for product development. Instead of treating regulatory affairs as a bureaucratic hurdle, Laurie explains how the smartest companies leverage frameworks like ISO 13485 and the latest MHRA guidelines as a springboard to innovate faster, build manufacturing reliability, and scale smoothly from prototype to production.
Exhibit at Med-Tech Expo 2027 – https://med-techexpo.com/exhibitor-enquiry
Stay informed with the Med-Tech Insights Newsletter: https://account.med-technews.com/register
